A longitudinal study demonstrates predicting conversion from mild cognitive impairment to Alzheimer's disease, highlighting clinical implications.
Alzheimer\\\'s disease (AD), the leading cause of dementia worldwide, affects more than 55 million individuals and gen-erates annual healthcare costs exceeding two trillion USD [14]. A substantial proportion (30–40% per year) of pa-tients with mild cognitive impairment (MCI) progress to AD [2], making early and accurate prognostication essential for timely intervention, trial enrichment, and resource allocation. This paper presents a comprehensive review of a re-cent longitudinal MRI-based study by Aghajanian et al. [1], which integrates three-dimensional (3D) convolutional neural networks (CNNs), time-aware long short-term memory (T-LSTM) networks with attention mechanisms, and radiomics features to predict MCI-to-AD conversion using structural MRI. The cohort comprises 228 ADNI MCI participants with at least three T1-weighted MRI scans over an 18-month window (684 scans in total) [1]. A 3D Res-Net-18 backbone [9] extracts volumetric features, fed into a T-LSTM incorporating inter-scan intervals and attention mechanisms [10]. The best longitudinal model achieves a concordance index (c-index) of 0.90, with time-specific AUCs of 0.96, 0.94, and 0.89 for 2-, 3-, and 5-year conversion prediction, respectively, and an approximate 11-fold hazard ratio between high- and low-risk groups [1]. This review analyzes the methodology, highlights its strengths and weaknesses, and discusses key implications for clinical translation.
No takes yet. Share an insight, caveat, or question.
Pawar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: